The interaction of insulin-like growth factor-I with the N-terminal domain of IGFBP-5

EMBO Journal

Volumn 20, Issue 14, 2001, Pages 3638-3644

  Zesławski, Wojciech ^a   Beisel, Hans Georg ^a   Kamionka, Mariusz ^a   Kalus, Wenzel ^a   Engh, Richard A ^b   Huber, Robert ^a   Lang, Kurt ^b   Holak, Tad A ^a  

^a MAX PLANCK INSTITUTE OF BIOCHEMISTRY   (Germany)

^b ROCHE DIAGNOSTICS GMBH   (Germany)

Author keywords

Cancer; Complex; IGFBP 5; Insulin like growth factor; Structure

Indexed keywords

SOMATOMEDIN; SOMATOMEDIN BINDING PROTEIN 5; SOMATOMEDIN C RECEPTOR;

AMINO TERMINAL SEQUENCE; ARTICLE; BINDING SITE; CELL PROLIFERATION; CELL SURFACE; MALIGNANT TRANSFORMATION; NUCLEAR MAGNETIC RESONANCE; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN DOMAIN; PROTEIN FAMILY; PROTEIN PROTEIN INTERACTION; PROTEIN STRUCTURE; RECEPTOR BINDING;

AMINO ACID SEQUENCE; BINDING SITES; INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN 5; INSULIN-LIKE GROWTH FACTOR I; MODELS, MOLECULAR; MOLECULAR SEQUENCE DATA; PROTEIN CONFORMATION; RECEPTOR, IGF TYPE 1; SEQUENCE HOMOLOGY, AMINO ACID;

EID: 0035898613     PISSN: 02614189     EISSN: None     Source Type: Journal    
DOI: 10.1093/emboj/20.14.3638     Document Type: Article

References (39)

1. Methods used in the structure determination of bovine mitochondrial F1 ATPase
2. Structure of rhombohedral 2 zinc insulin crystals
3. Binding of mutants of human insulin-like growth factor II to insulin-like growth factor binding proteins 1-6
4. Structural determinants for binary and ternary complex formation between insulin-like growth factor-I (IGF-I) and IGF binding protein-3
5. The roles of tyrosine 24, 31, and 60 in the high affinity binding of insulin-like growth factor-I and the type 1 insulin-like growth factor receptor
6. Insulin-like growth factor: A model for tertiary structure accounting for immunoreactivity and receptor binding
7. Crystallography and NMR system - A new software suite for macromolecular structure determination
8. Insulin-like growth factor-binding protein-3 modulates expression of Bax and Bcl-2 and potentiates p53-independent radiation-induced apoptosis in human breast cancer cells
9. Mutants of human insulin-like growth factor I with reduced affinity for the type I insulin-like growth factor receptor
10. Proteolytic cleavage of insulin-like growth factor binding protein 4 (IGFBP-4). Localization of cleavage site to non-homologous region of native IGFBP-4
11. The CCP4 suite: Programs for protein crystallography
12. Solution structure of human insulin-like growth factor 1: A nuclear magnetic resonance and restrained molecular dynamics study
13. Growth inhibition by insulin-like growth factor binding protein-3 in T47D breast cancer cells requires transforming growth factor-β (TGF-β) and type II TGF-β receptor
14. Engineering the C-region of human insulin-like growth factor-I. Implications for receptor binding
15. Circulating concentrations of insulin-like growth factor I and risk of breast cancer
16. Insulin-like growth factor-I and new opportunities for cancer prevention
17. Receptor binding redefined by a structural switch in a mutant human insulin
18. The IGF binding protein superfamily
19. Substitutions for hydrophobic amino acids in the N-terminal domains of IGFBP-3 and -5 markedly reduce IGF-I binding and alter their biologic actions
20. Structural changes in insulin-like growth factor IGF I mutant proteins affecting binding kinetic rates to IGF binding protein 1 and IGF-I receptor
21. Insulin-like growth factors and their binding proteins: Biological actions
22. Improved methods for building protein models in electron density maps and the location of errors in these models
23. Structure of the IGF binding domain of the insulin-like growth factor-binding protein-5 (IGFBP-5): Implications for IGF and IGF-I receptor interactions
24. The effects of insulin-like growth factors on tumorigenesis and neoplastic growth
25. Solution structure and backbone dynamics of long-[Arg3]insulin-like growth factor-I
26. Maximum-likelihood heavy-atom parameter refinement for multiple isomorphous replacement and multiwavelength anomalous diffraction methods
27. Automated refinement of protein models
28. Molecular data processing
29. Displacement of insulin-like growth factors from their binding proteins as a potential treatment for stroke
30. Mutants of human insulin-like growth factor II (IGF II). Expression and characterization of truncated IGF II and of two naturally occurring variants
31. IGF binding proteins as modulators of IGF actions
32. Insulin-like growth factor binding protein-4 proteolytic degradation in ovine preovulatory follicles: Studies of underlying mechanisms
33. Structure and evolution of insulins: Implications for receptor binding
34. 1H NMR and distance geometry
35. Tutorial on automated Patterson interpretation to find heavy atoms
36. Solution structure of human insulin-like growth factor II; recognition sites for receptors and binding proteins
37. Solution structure of human insulin-like growth factor II. Relationship to receptor and binding protein interactions
38. Novel aspects of the insulin-like growth factor binding proteins
39. Can measurements of IGF-1 and IGFBP-3 improve the sensitivity of prostate-cancer screening